panadol multisintomas tabletas
glaxosmithkline panama, s.a. - acetaminofen en polvo, usp - acetaminofen en polvo, usp....500.00 mg / fenilefrina hcl usp....5.00 mg / maleato de clorfeniramina, usp....2.00 mg / dextrometorfan hbr usp....15.00 mg
nor-cetin forte multisintomas tabletas
laboratorios teramed s.a. de c.v. - clorfeniramina maleato - clorfeniramina maleato....4.000mg (1) / dextrometorfano bromhidrato....20.000mg (1) / fenilefrina clorhidrato....10.00mg (1)
tramadol denk 50
losan pharma gmbh otto- hahn-str. 13 79395 neuenburg for denk pharma gmbh & co. kg - tramadol (tramadol hydrochloride) - tablets effervescent - 50mg
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 0.5 mg/ml - solution for infusion - 0.5 mg/ml - active: baclofen 0.5 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 2 mg/ml - solution for infusion - 2 mg/ml - active: baclofen 2 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 0.05 mg/ml - solution for injection - 0.05 mg/ml - active: baclofen 0.05 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
infanrix hexa powder and suspension for suspension for injection
glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, pertactin, hepatitis b surface antigen, inactivated poliovirus type 1, inactivated poliovirus type 2, inactivated poliovirus type 3, haemophilus influenzae type b polysaccharide (conjugated to tetanus toxoid) - powder and suspension for suspension for injection - not less than 30iu/dose+ not less than 40iu/dose+ 25mcg/dose+ 25mcg/dose+ 8mcg/dose+ 10mcg/dose+ 40d-antigen unit/dose+ 8d-antig
toras-denk 5 tablets
denk pharma gmbh & co. kg - torasemide - tablets - 5mg
toras-denk 10 tablets
denk pharma gmbh & co. kg - torasemide - tablets - 10mg
toras-denk 5 tablets
denk pharma gmbh & co. kg - torasemide - tablets - 5mg